In Wacharasint and colleagues' cohort of patients in septic shock, the obese had decreased mortality. Surprisingly, this was seen even in the subcohort of morbidly obese patients [1] . Infection profi les diff ered, with lower rates of lung and fungal infection in the obese. Like other studies, they found that most intensivists still approach adults of varying weights with uniform doses of fl uid and vasopressors.
us, the obese received a lower weightbased dose. e signifi cance of this is still speculative. Excessive fl uid resuscitation may cause harm [8] . Perhaps the lower weight-based dose confoundingly leads to a perceived protective eff ect of obesity.
Sussing out useful information on the critically ill obese remains diffi cult. It appears that obese patients may respond diff erently than nonobese patients in critical illness. e basis for this, though, is unknown. Given the contradictory data on infl ammatory markers, it is likely that the appropriate complement of markers for study in critical illness remains unidentifi ed. Despite the known diffi culties of ventilating obese patients given decreased chest wall compliance, increased gastric refl ux, increased ventilator-associated pneumonia, and Wacharasint and colleagues' fi nding of inappropriately high tidal volumes during mechanical ventilation when compared to their nonobese cohort, the obese still had lower rates of lung infection [1] . ese mortality data contradict earlier fi ndings in the critically ill morbidly obese and the use of low tidal volumes in acute lung injury [5, 6, 9] .
How can we explain the decreased mortality in the obese, particularly the morbidly obese, observed in this and other studies [1, 3] ? We agree that the obese have a diff erent immune response in critical illness. We acknowledge that the Acute Physiology and Chronic Health Evaluation scoring systems overestimate the severity of illness in the obese by incorporating markers that diff er in otherwise healthy obese patients, like creatinine and oxygenation.
ere are three possible explanations for how the obese, especially morbidly obese, may experience better outcomes in the ICU today as compared to decades past. First, and most likely, this special population has received heightened attention and the consequence has been improved outcomes [10, 11] . e study of pharmacokinetics in the obese has advanced. ICUs have developed better turning, skin, mobilization, oral, and pulmonary toilet protocols. Newer mattresses and beds attenuate pressure sore formation. It is possible our inadvertent 'under' dosing of obese patients' fl uids and vasopressors conferred a protective eff ect. Indirect calorimetry can accurately estimate energy expenditure in the obese. Use of ultrasound when obtaining vascular access has decreased complications. Imaging tables that support the greater weight of morbidly obese patients have opened up modalities and improved the diagnosis of life-threaten ing illness. Improvements in glycemic control have benefi ted the obese, who are likelier to have dysglycemia and diabetes. Improved ventilation and extubation protocols have probably improved outcomes in the obese who have higher rates of atelectasis, hypoxemia, and obstructive sleep apnea.
Second, the observation of an obesity paradox in critical illness typically arises from retrospective or post hoc analyses or meta-analyses of the same. ese studies pose interesting questions but do not prove the existence of an obesity paradox. Even when matching severity of illness in the obese and non-obese, scoring systems do not do justice when comparing a 70 kg patient with a 270 kg patient. Scoring systems have never been validated in the obese. Moreover, one must discriminate between mild obesity and morbid obesity. It may be that outcomes in the mildly obese are no worse than for normal or overweight subjects.
ird, the fi nding of an obesity paradox in the critically ill, counter to general population outcomes, may be a mirage, an optical phenomenon that does not actually exist. at morbid obesity is 'protective' in critical illness strongly confl icts with bedside observations in the crucible of real life. In the morbidly obese, emergency airway or vascular access can be diffi cult to secure, chest compressions are less eff ective, and simply turning a morbidly obese patient may require up to eight bedside providers. Overall, the protective eff ect of morbid obesity in critical illness does not pass the 'smell test' for those working bedside. Discrepant fi ndings in suboptimal studies underscore our lack of understanding of obesity, infl ammation and critical illness, and the need for further research.
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